The Albus is a program whose aim is to foster the creation of a scientific network and to increase the knowledge in the use of albumin as a therapeutic product. By supporting this program Grifols demonstrates its commitment to innovation in this field. We consider the program to be a tangible contribution to the improvement of standards and benefits for the patient care.

Applications for the Albus Awards 2023 will be accepted between 01/11/2022 and 31/05/2023.

Please click here to apply.

To see the 2022 ALBUS Award winners please click here.